Evidence map›Paper›PMID 19243304›Full record

ReviewFuture oncology (London, England)2009

Watching the watcher: regulation of p53 by mitochondria.

Aaron K Holley, Daret K St Clair

Abstract readReview
In one paragraph

Review in Future oncology (London, England), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. A systematic review of p53 regulation of oxidative stress in skeletal muscle.Redox report : communications in free radical research · 2018
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. p53: key conductor of all anti-acne therapies.Journal of translational medicine · 2017
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Aaron K HolleyGraduate Center for Toxicology, University of Kentucky, Lexington, KY 40536, USA.
Daret K St Clair

Funding

REDOX REGULATION OF TUMOR SUPPRESSION BY MNSODR01CA073599 · NCI · UNIVERSITY OF KENTUCKY · PI ST CLAIR, DARET K · 1998 to 2012
$4.0M
Mechansins of MnSOD expression in normal and tumor cellsR01CA049797 · NCI · UNIVERSITY OF KENTUCKY · PI ST CLAIR, DARET K · 1996 to 2014
$3.3M
MbSOD in chemotherapeutic-Induced Cardiac InjuryR01CA139843 · NCI · UNIVERSITY OF KENTUCKY · PI ST CLAIR, DARET K · 2008 to 2012
$1.3M
NCI NIH HHS R01 CA049797NCI NIH HHS R01 CA073599NCI NIH HHS R01 CA139843
6 · The paper itself

Abstract

p53 has been referred to as the 'guardian of the genome' because of its role in protecting the cell from DNA damage. p53 performs its duties by regulating cell-cycle progression and DNA repair and, in cases of irreparable DNA damage, by executing programmed cell death. Mitochondria are an important target of transcription-dependent and -independent actions of p53 to carry out the apoptotic function. However, increasing evidence suggests that p53 activity is regulated by mitochondria. Cellular insults that alter mitochondrial function can have important consequences on p53 activity. In light of these new findings, the following review focuses on p53/mitochondria connections, in particular how reactive oxygen species generated at mitochondria regulate p53 activity. A better understanding of the mechanisms by which mitochondria regulate p53 may have an impact on our understanding of the development and progression of many diseases, especially cancer.

Indexed as

AnimalsApoptosisHumansMitochondriaNeoplasmsReactive Oxygen SpeciesTumor Suppressor Protein p53Reactive Oxygen SpeciesTumor Suppressor Protein p53

Identifiers

PMID19243304
PMCPMC2710969

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.